日本語View as Markdown

Hydrogen-rich saline prevents neointima formation after carotid balloon injury by suppressing ROS and the TNF-α/NF-κB pathway.

水素豊富生理食塩水による頸動脈バルーン傷害後の新生内膜形成抑制:ROSおよびTNF-α/NF-κB経路の関与

animal study injection / infusion positive

Abstract

This study examined the effects of daily hydrogen-rich saline solution (HRSS) injection in a rat carotid balloon-injury model. Animals receiving HRSS showed a significant reduction in neointima area and intima-to-media ratio, along with fewer PCNA-positive proliferating cells in the intimal layer. In the injured carotid arteries, ROS and malondialdehyde (MDA) levels declined, while superoxide dismutase (SOD) activity and reduced glutathione (GSH) concentrations increased. Inflammatory mediators including IL-6, TNF-α, and NF-κB p65 were also markedly reduced. Complementary cell-culture experiments demonstrated that hydrogen solution inhibited PDGF-BB-induced vascular smooth muscle cell (VSMC) proliferation and attenuated ROS generation. Collectively, the findings indicate that HRSS may limit post-angioplasty restenosis partly by scavenging local ROS and downregulating the TNF-α/NF-κB signaling axis.

Mechanism

HRSS scavenges local reactive oxygen species and suppresses the TNF-α/NF-κB signaling pathway, thereby reducing vascular smooth muscle cell proliferation and inflammatory cytokine production to limit neointima formation after arterial injury.

Bibliographic

Authors
Qin ZX, Yu P, Qian DH, Song MB, Tan H, Yu Y, et al.
Journal
Atherosclerosis
Year
2012
PMID
22153150
DOI
10.1016/j.atherosclerosis.2011.11.002

Tags

Disease:動脈硬化 Delivery:点滴投与 Mechanism:抗酸化酵素 グルタチオン 炎症抑制 脂質過酸化 酸化ストレス 活性酸素種

Delivery context

Intravenous hydrogen-saline infusion is a clinic-only route and is not viable for everyday self-administration. For routine hydrogen intake, inhalation is the most practical route, but inhalation carries explosion risk and concentration matters (empirical LFL of 10%; high-concentration 66% / 100% devices are not recommended).

Safety notes

Intravenous hydrogen-saline infusion is a clinic-only route and is not viable for everyday self-administration. For routine hydrogen intake, inhalation is the most practical route, but inhalation carries explosion risk and concentration matters (empirical LFL of 10%; high-concentration 66% / 100% devices are not recommended).

See also:

Other papers on the same disease / condition

Cite as: H2 Papers — PMID 22153150. https://h2-papers.org/en/papers/22153150
Source: PubMed PMID 22153150